| Serial Number | 88524189 |
| Word Mark | MILESTONE PHARMACEUTICALS |
| Filing Date | Friday, July 19, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 2, 2023 |
| Registration Number | 7039322 |
| Registration Date | Tuesday, May 2, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 14, 2023 |
| Goods and Services | Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of cardiovascular disorders; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of cardiovascular disorders |
| Goods and Services | Providing a resource website featuring information in the field of the treatment of episodic cardiovascular conditions; providing a resource website featuring information for people living with atrial fibrillation/atrial flutter; providing a resource website featuring information for people living with myocardial ischemia including angina; providing a resource website featuring information for people living with supraventricular tachycardias including paroxysmal |
| Disclaimer with Predetermined Text | "PHARMACEUTICALS" |
| Goods and Services | Providing medical and scientific research information in the field of heart disease and clinical trials; providing medical and scientific research information in the field of cardiovascular disorders and clinical trials; pharmaceutical research services in the field of heart disease and cardiovascular system; pharmaceutical drug development services in the field of heart disease and cardiovascular system; pharmaceutical research and development in the field of heart disease and cardiovascular system; medical and scientific research, namely, conducting clinical trials for others in the field of heart disease and cardiovascular system; providing medical and scientific research information in the field of pharmaceuticals and clinical trials |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 29, 2019 |
| Primary Code | 035 |
| First Use Anywhere Date | Thursday, November 30, 2006 |
| First Use In Commerce Date | Thursday, November 30, 2006 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 29, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, November 30, 2006 |
| First Use In Commerce Date | Thursday, November 30, 2006 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 25, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | Thursday, November 30, 2006 |
| First Use In Commerce Date | Thursday, November 30, 2006 |
| Party Name | Milestone Pharmaceuticals USA, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Charlotte, NC 28277 |
| Party Name | Milestone Pharmaceuticals USA, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Charlotte, NC 28277 |
| Party Name | Milestone Pharmaceuticals USA, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Charlotte, NC 28277 |
| Event Date | Event Description |
| Wednesday, July 12, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, July 12, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, July 12, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, May 2, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, May 2, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, February 14, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 14, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 25, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, January 12, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Saturday, December 31, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, December 31, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, December 31, 2022 | ASSIGNED TO LIE |
| Friday, November 4, 2022 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Sunday, May 8, 2022 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Sunday, May 8, 2022 | FINAL REFUSAL E-MAILED |
| Sunday, May 8, 2022 | FINAL REFUSAL WRITTEN |
| Friday, October 1, 2021 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Thursday, April 1, 2021 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Thursday, October 1, 2020 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Wednesday, April 1, 2020 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, April 1, 2020 | LETTER OF SUSPENSION E-MAILED |
| Wednesday, April 1, 2020 | SUSPENSION LETTER WRITTEN |
| Wednesday, March 25, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 24, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, March 24, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, September 24, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, September 24, 2019 | NON-FINAL ACTION E-MAILED |
| Tuesday, September 24, 2019 | NON-FINAL ACTION WRITTEN |
| Sunday, September 22, 2019 | ASSIGNED TO EXAMINER |
| Monday, July 29, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, July 23, 2019 | NEW APPLICATION ENTERED |